Daniel Faga Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Daniel Faga.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Daniel Faga. Daniel Faga is EVP, Chief Operating Officer in Mirati Therapeutics, Inc. ($MYG) and Chief Business Officer in Spark Therapeutics, Inc. ($ONCE).
Latest Insider Trading Transactions of Daniel Faga
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 03 2021 | MYG | Mirati Therapeutic ... | Faga Daniel | EVP, Chief Operatin ... | Option Exercise | M | 114.33 | 1,340 | 153,202 | 63,630 | |
| Feb 03 2021 | MYG | Mirati Therapeutic ... | Faga Daniel | EVP, Chief Operatin ... | Sell | S | 194.38 | 1,340 | 260,469 | 30,638 | 32 K to 30.6 K (-4.19 %) |
| Feb 03 2021 | MYG | Mirati Therapeutic ... | Faga Daniel | EVP, Chief Operatin ... | Buy | M | 114.33 | 1,340 | 153,202 | 31,978 | 30.6 K to 32 K (+4.37 %) |
| Jan 20 2021 | MYG | Mirati Therapeutic ... | Faga Daniel | EVP, Chief Operatin ... | Option Exercise | A | 214.47 | 10,979 | 2,354,666 | 10,979 | |
| Jan 20 2021 | MYG | Mirati Therapeutic ... | Faga Daniel | EVP, Chief Operatin ... | Grant | A | 0.00 | 7,023 | 0 | 30,638 | 23.6 K to 30.6 K (+29.74 %) |
| Jan 08 2021 | MYG | Mirati Therapeutic ... | Faga Daniel | EVP, Chief Operatin ... | Sell | S | 216.33 | 2,613 | 565,270 | 23,615 | 26.2 K to 23.6 K (-9.96 %) |
| Jan 08 2021 | MYG | Mirati Therapeutic ... | Faga Daniel | EVP, Chief Operatin ... | Sell | S | 215.31 | 12 | 2,584 | 26,228 | 26.2 K to 26.2 K (-0.05 %) |
| Jan 08 2020 | MYG | Mirati Therapeutic ... | Faga Daniel | EVP, Chief Operatin ... | Option Exercise | A | 114.33 | 64,970 | 7,428,020 | 64,970 | |
| Jan 08 2020 | MYG | Mirati Therapeutic ... | Faga Daniel | EVP, Chief Operatin ... | Grant | A | 0.00 | 26,240 | 0 | 26,240 | 0 to 26.2 K |
| Jan 08 2020 | MYG | Mirati Therapeutic ... | Faga Daniel | EVP, Chief Operatin ... | Option Exercise | A | 114.33 | 64,970 | 7,428,020 | 64,970 | |
| Jan 08 2020 | MYG | Mirati Therapeutic ... | Faga Daniel | EVP, Chief Operatin ... | Grant | A | 0.00 | 26,240 | 0 | 26,240 | 0 to 26.2 K |
| Dec 17 2019 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Option Exercise | D | 0.00 | 21,500 | 0 | 0 | |
| Dec 17 2019 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Option Exercise | D | 37.62 | 50,000 | 1,881,000 | 0 | |
| Dec 17 2019 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Option Exercise | D | 56.17 | 14,000 | 786,380 | 0 | |
| Dec 17 2019 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Option Exercise | D | 50.55 | 26,250 | 1,326,938 | 0 | |
| Dec 17 2019 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Option Exercise | D | 42.73 | 35,000 | 1,495,550 | 0 | |
| Dec 17 2019 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Sell | U | 114.50 | 38,828 | 4,445,806 | 0 | 38.8 K to 0 (-100.00 %) |
| Mar 27 2019 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Option Exercise | M | 50.55 | 8,750 | 442,313 | 26,250 | |
| Mar 27 2019 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Option Exercise | M | 56.17 | 14,000 | 786,380 | 14,000 | |
| Mar 27 2019 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Option Exercise | M | 37.62 | 80,000 | 3,009,600 | 50,000 | |
| Mar 27 2019 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Payment of Exercise | F | 113.43 | 6,228 | 706,442 | 38,828 | 45.1 K to 38.8 K (-13.82 %) |
| Mar 27 2019 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Buy | M | 50.55 | 8,750 | 442,313 | 45,056 | 36.3 K to 45.1 K (+24.10 %) |
| Mar 27 2019 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Payment of Exercise | F | 113.43 | 10,325 | 1,171,165 | 36,306 | 46.6 K to 36.3 K (-22.14 %) |
| Mar 27 2019 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Buy | M | 56.17 | 14,000 | 786,380 | 46,631 | 32.6 K to 46.6 K (+42.90 %) |
| Mar 27 2019 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Payment of Exercise | F | 113.42 | 51,401 | 5,829,901 | 32,631 | 84 K to 32.6 K (-61.17 %) |
| Mar 27 2019 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Buy | M | 37.62 | 80,000 | 3,009,600 | 84,032 | 4 K to 84 K (+1,984.13 %) |
| Jan 23 2019 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Option Exercise | M | 0.00 | 2,500 | 0 | 7,500 | |
| Jan 23 2019 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Option Exercise | M | 0.00 | 2,000 | 0 | 4,000 | |
| Jan 23 2019 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Payment of Exercise | F | 45.08 | 823 | 37,101 | 4,032 | 4.9 K to 4 K (-16.95 %) |
| Jan 23 2019 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Buy | M | 0.00 | 2,500 | 0 | 4,855 | 2.4 K to 4.9 K (+106.16 %) |
| Jan 23 2019 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Payment of Exercise | F | 45.08 | 766 | 34,531 | 2,355 | 3.1 K to 2.4 K (-24.54 %) |
| Jan 23 2019 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Buy | M | 0.00 | 2,000 | 0 | 3,121 | 1.1 K to 3.1 K (+178.41 %) |
| Jan 17 2019 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
| Jan 17 2019 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Option Exercise | A | 42.73 | 35,000 | 1,495,550 | 35,000 | |
| Jan 17 2019 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
| Jan 17 2019 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Option Exercise | A | 42.73 | 35,000 | 1,495,550 | 35,000 | |
| Jan 22 2018 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Option Exercise | M | 0.00 | 2,000 | 0 | 6,000 | |
| Jan 22 2018 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
| Jan 22 2018 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Option Exercise | A | 50.55 | 35,000 | 1,769,250 | 35,000 | |
| Jan 22 2018 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Payment of Exercise | F | 50.55 | 879 | 44,433 | 1,121 | 2 K to 1.1 K (-43.95 %) |
| Jan 22 2018 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Buy | M | 0.00 | 2,000 | 0 | 2,000 | 0 to 2 K |
| Oct 24 2017 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Option Exercise | M | 37.62 | 1,500 | 56,430 | 130,000 | |
| Oct 24 2017 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Option Exercise | M | 37.62 | 6,000 | 225,720 | 131,500 | |
| Oct 24 2017 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Sell | S | 85.00 | 1,500 | 127,500 | 0 | 1.5 K to 0 (-100.00 %) |
| Oct 24 2017 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Buy | M | 37.62 | 1,500 | 56,430 | 1,500 | 0 to 1.5 K |
| Oct 24 2017 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Sell | S | 79.95 | 6,000 | 479,700 | 0 | 6 K to 0 (-100.00 %) |
| Oct 24 2017 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Buy | M | 37.62 | 6,000 | 225,720 | 6,000 | 0 to 6 K |
| Sep 20 2017 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Option Exercise | M | 37.62 | 1,500 | 56,430 | 137,500 | |
| Sep 20 2017 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Sell | S | 85.00 | 1,500 | 127,500 | 0 | 1.5 K to 0 (-100.00 %) |
| Sep 20 2017 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Buy | M | 37.62 | 1,500 | 56,430 | 1,500 | 0 to 1.5 K |
| Sep 14 2017 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Option Exercise | M | 37.62 | 6,000 | 225,720 | 139,000 | |
| Sep 14 2017 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Sell | S | 83.36 | 900 | 75,024 | 0 | 900 to 0 (-100.00 %) |
| Sep 14 2017 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Sell | S | 82.35 | 5,100 | 419,985 | 900 | 6 K to 900 (-85.00 %) |
| Sep 14 2017 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Buy | M | 37.62 | 6,000 | 225,720 | 6,000 | 0 to 6 K |
| Sep 11 2017 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Option Exercise | M | 37.62 | 3,000 | 112,860 | 145,000 | |
| Sep 11 2017 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Sell | S | 85.03 | 1,500 | 127,545 | 0 | 1.5 K to 0 (-100.00 %) |
| Sep 11 2017 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Sell | S | 85.00 | 1,500 | 127,500 | 1,500 | 3 K to 1.5 K (-50.00 %) |
| Sep 11 2017 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Buy | M | 37.62 | 3,000 | 112,860 | 3,000 | 0 to 3 K |
| Jul 26 2017 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Option Exercise | M | 37.62 | 3,000 | 112,860 | 148,000 | |
| Jul 26 2017 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Sell | S | 70.00 | 3,000 | 210,000 | 0 | 3 K to 0 (-100.00 %) |
| Jul 26 2017 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Buy | M | 37.62 | 3,000 | 112,860 | 3,000 | 0 to 3 K |
| Jun 29 2017 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Option Exercise | M | 37.62 | 4,500 | 169,290 | 151,000 | |
| Jun 29 2017 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Sell | S | 62.71 | 4,500 | 282,195 | 0 | 4.5 K to 0 (-100.00 %) |
| Jun 29 2017 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Buy | M | 37.62 | 4,500 | 169,290 | 4,500 | 0 to 4.5 K |
| May 17 2017 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Option Exercise | M | 37.62 | 4,500 | 169,290 | 155,500 | |
| May 17 2017 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Sell | S | 56.90 | 4,500 | 256,050 | 0 | 4.5 K to 0 (-100.00 %) |
| May 17 2017 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Buy | M | 37.62 | 4,500 | 169,290 | 4,500 | 0 to 4.5 K |
| Jan 20 2017 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Option Exercise | A | 0.00 | 8,000 | 0 | 8,000 | |
| Jan 20 2017 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Option Exercise | A | 56.17 | 28,000 | 1,572,760 | 28,000 | |
| May 04 2016 | ONCE | Spark Therapeutics ... | Faga Daniel | Chief Business Offi ... | Option Exercise | A | 37.62 | 160,000 | 6,019,200 | 160,000 |
Page: 1